SUBSCRIBE

EMA accepts application for ranibizumab biosimilar from Samsung Bioepis

 Posted 23/10/2020

Korea-based Samsung Bioepis (Samsung and Biogen’s joint venture) announced on 6 October 2020 that the European Medicines Agency (EMA) has accepted to review...

more
Biosimilar assessments: do we need efficacy tri... Biosimilars/Research | Posted 23/10/2020
Commercialization challenges for biosimilar orp... Reports | Posted 23/10/2020
Biopharmaceuticals and biosimilars: manufacturi... Biosimilars/Research | Posted 23/10/2020
China’s draft measures for patent linkage system Policies & Legislation | Posted 23/10/2020
Reforms to health policy needed in Europe Generics/General | Posted 23/10/2020
Aurobindo and Huons refocus their biologicals/b... Pharma News | Posted 23/10/2020
Medicare Part D favours generics over brand-nam... Generics/Research | Posted 23/10/2020
Biopharmaceuticals and biosimilars: manufacturi... Biosimilars/Research | Posted 16/10/2020
EC approval for bevacizumab biosimilar Equidacent Biosimilars/News | Posted 16/10/2020
Clinical development challenges faced by orphan... Reports | Posted 16/10/2020
China accepts application for bevacizumab copy... Biosimilars/News | Posted 16/10/2020
Lotus to distribute CKD’s biosimilar darbepoeti... Pharma News | Posted 16/10/2020
Pharmacists are key to quality use of medicines... Biosimilars/Research | Posted 16/10/2020
Sun Pharma launches Ilumya in Japan and favipir... Generics/News | Posted 16/10/2020
Australian diabetes organizations issue biosimi... Biosimilars/General | Posted 16/10/2020
ST002293
Clinical review of biosimilars approved in onco... Biosimilars/Research | Posted 09/10/2020
18794124_l
Henlius and Accord collaborations will see thei... Pharma News | Posted 09/10/2020
Biopharmaceuticals and biosimilars: challenges... Biosimilars/Research | Posted 09/10/2020
China approves adalimumab copy biological Sulinno Biosimilars/News | Posted 09/10/2020
The landscape for orphan drugs in Europe Reports | Posted 09/10/2020
Structural reforms are required to make Japan’s... Generics/General | Posted 09/10/2020
Mylan/Synthon win European patent ruling on gen... Policies & Legislation | Posted 09/10/2020
Generics and biosimilars can save Ireland Euros... Reports | Posted 09/10/2020
Why biosimilar applications fail during regulat... Biosimilars/Research | Posted 02/10/2020
China’s drug agency proposes changes to patent law Guidelines | Posted 02/10/2020
Spectroscopy remains dominant when investigatin... Biosimilars/Research | Posted 02/10/2020
Cadila launches two new similar biologics in India Biosimilars/News | Posted 02/10/2020
Biocon and Celltrion make progress in the battl... Biosimilars/News | Posted 02/10/2020
Mylan-Upjohn merger receives go ahead from Euro... Pharma News | Posted 02/10/2020
16704526_l
Sustainable market scorecard represents gold-st... Biosimilars/General | Posted 02/10/2020
Out-of-pocket spending caps cut patient spendin... Generics/Research | Posted 02/10/2020
Phase III trial updates of Samsung Bioepis’ bev... Biosimilars/Research | Posted 25/09/2020
Indications expanded for Merck’s etanercept bio... Biosimilars/News | Posted 25/09/2020
FDA to investigate PD biomarkers to show biosim... Biosimilars/Research | Posted 25/09/2020
Bio-Thera and BeiGene sign deal to license, dis... Pharma News | Posted 25/09/2020
FDA invites comments on research into disclosur... Policies & Legislation | Posted 25/09/2020
FDA updates Purple Book database Biosimilars/General | Posted 25/09/2020
EMA recommends approval for arsenic trioxide an... Generics/News | Posted 25/09/2020
FDA’s new MAPP explains route for changing owne... Guidelines | Posted 25/09/2020
Insulin glargine biosimilar Semglee launched in US Biosimilars/News | Posted 18/09/2020
Biosimilars allow fast access to biological dru... Biosimilars/Research | Posted 18/09/2020
Brazil publishes pathway for accelerating innov... Policies & Legislation | Posted 18/09/2020
Ligand to acquire biosimilars manufacturer Pfenex Pharma News | Posted 18/09/2020
What oncologists do not understand about biosim... Biosimilars/Research | Posted 18/09/2020
The benefits of tracking generic drug quality Generics/General | Posted 18/09/2020
Country scorecards show biosimilar sustainability Biosimilars/General | Posted 18/09/2020
Inter partes review and the generic drug industry Policies & Legislation | Posted 18/09/2020
Budget savings from biosimilar infliximab in th... Biosimilars/Research | Posted 11/09/2020
Turkey 2016 COVER V16E31DG
Samsung Bioepis launches Ontruzant in Brazil Biosimilars/News | Posted 11/09/2020
more

NON-BIOLOGICAL COMPLEX DRUGS

FDA issues final guidance on liposome drug products Posted 27/04/2018

On 4 April 2018, the US Food and Drug Administration (FDA) issued a new draft...

more


FDA approves 40 mg follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 09/03/2018
Mylan launches first follow-on glatiramer aceta... Non‐Biological Complex Drugs/News | Posted 15/02/2018
Biosimilars and follow-on NBCDs for MS in Europ... Non‐Biological Complex Drugs/Research | Posted 19/01/2018
Impax announces FDA approval of follow-on sevel... Non‐Biological Complex Drugs/News | Posted 17/11/2017
FDA approves follow-on version of sevelamer Non‐Biological Complex Drugs/News | Posted 30/06/2017
Challenges in the regulation of NBCDs Non‐Biological Complex Drugs/Research | Posted 12/05/2017
Scientific and regulatory considerations for fo... Non‐Biological Complex Drugs/Research | Posted 05/05/2017
Equivalence of complex drug products Non‐Biological Complex Drugs/Reports | Posted 14/04/2017
Follow-up studies needed to ensure safety for f... Non‐Biological Complex Drugs/Research | Posted 31/03/2017
Warning letter causes delays for follow-on glat... Non‐Biological Complex Drugs/News | Posted 17/03/2017
Is the EU ready for non-biological complex drug... Non‐Biological Complex Drugs/Research | Posted 03/03/2017
Follow-on versions of glatiramer acetate in Rus... Non‐Biological Complex Drugs/News | Posted 24/02/2017
Non-biological complex drugs and pharmacopoeias Non‐Biological Complex Drugs/Research | Posted 10/02/2017
In vitro analysis of follow-on versions of seve... Non‐Biological Complex Drugs/Research | Posted 18/11/2016
Determining the bioequivalence of follow-on iro... Non‐Biological Complex Drugs/Reports | Posted 04/11/2016
FDA to set up abbreviated pathway for complex p... Non‐Biological Complex Drugs/Polices & Legislation | Posted 21/10/2016
Challenges in the assessment of ophthalmic emul... Non‐Biological Complex Drugs/Reports | Posted 07/10/2016
Cancer lab to evaluate bioequivalence of nanosi... Non‐Biological Complex Drugs/News | Posted 23/09/2016
A conference on ‘Equivalence of Complex Drug Pr... Non‐Biological Complex Drugs/News | Posted 09/09/2016
Collaboration to introduce nanotechnologies in... Non‐Biological Complex Drugs/News | Posted 26/08/2016
Iron carbohydrate follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 12/08/2016
Rigorous approach used to approve a follow-on v... Non‐Biological Complex Drugs/Research | Posted 29/07/2016
US guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 10/06/2016
Non-biological complex drugs and their follow-o... Non‐Biological Complex Drugs/Research | Posted 03/06/2016
Is a new pathway for NBCDs on the way in the US? Non‐Biological Complex Drugs/Polices & Legislation | Posted 27/05/2016
Follow-on glatiramer acetate gains European app... Non‐Biological Complex Drugs/News | Posted 13/05/2016
FDA includes follow-on versions in its new cycl... Non‐Biological Complex Drugs/Guidelines | Posted 29/04/2016
Switching between originator and follow-on iron... Non‐Biological Complex Drugs/Research | Posted 22/04/2016
Follow-on intravenous iron formulations in haem... Non‐Biological Complex Drugs/Research | Posted 01/04/2016
Glatiramoid follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/03/2016
FDA includes follow-on versions in its new lipo... Non‐Biological Complex Drugs/Guidelines | Posted 26/02/2016
EU guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 22/01/2016
GDUFA regulatory priorities for 2016 include co... Non‐Biological Complex Drugs/Polices & Legislation | Posted 11/12/2015
Liposomal follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/12/2015
Regulations for follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 13/11/2015
Status and regulatory issues surrounding follow... Non‐Biological Complex Drugs/Reports | Posted 05/11/2015
Follow-on glatiramer acetate (M356) claimed as... Non‐Biological Complex Drugs/Research | Posted 05/11/2015
EMA issues reflection paper for follow-on versi... Non‐Biological Complex Drugs/Guidelines | Posted 05/11/2015
FDA approves first follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 05/11/2015
more

Country Focus

All countries

Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!

Generics News Research General

more

Biosimilars News Research General

more

More editorial sections